Therefore, although the level of EphA1 expression in human cancer cells used in this study is very low (Supplementary Fig. 10), it is essential to characterize whether the serine residue of EphA1 is a substrate for RSK or Akt. This evidence concerns the gene RPS6KA1 and cancer.